🇺🇸 FDA

Intelligence · Clinical Pipeline

R&D Pipeline Programs

ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.

Programs indexed
18,156
Companies
1,062
Drugs tracked
3,385

Quick answer

NovaPharmaNews tracks 18,156 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.

1,187 results for “Takeda” Clear

  1. Pantoprazole

    Takeda Pharmaceuticals International AG

    GERD

    phase 3 small molecule completed

    1 trial

  2. Parathyroid Hormone (PTH)

    Takeda Pharmaceuticals International AG

    Osteoporosis

    phase 3 small molecule completed

    1 trial

  3. Parathyroid hormone

    Takeda Pharmaceuticals International AG

    Disruption or Dehiscence of Closure of Sternum or Sternotomy

    phase 3 small molecule completed

    1 trial

  4. Pioglitazone

    Takeda Pharmaceuticals International AG

    HIV-Associated Lipodystrophy Syndrome

    phase 3 small molecule terminated

    1 trial

  5. Pioglitazone

    Takeda Pharmaceuticals International AG

    Mild Cognitive Impairment Due to Alzheimer's Disease

    phase 3 small molecule terminated

    2 trials

  6. Pioglitazone

    Takeda Pharmaceuticals International AG

    Impaired Glucose Tolerance

    phase 3 small molecule completed

    1 trial

  7. Pioglitazone and Azilsartan

    Takeda Pharmaceuticals International AG

    Type 2 Diabetes

    phase 3 small molecule terminated

    1 trial

  8. Pioglitazone and Glimepiride

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus

    phase 3 small molecule completed

    1 trial

  9. Pioglitazone-Azilsartan

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus, Type 2

    phase 3 small molecule terminated

    1 trial

  10. Placebo

    Takeda Pharmaceuticals International AG

    Generalized Anxiety Disorder

    phase 3 small molecule completed

    1 trial

  11. Placebo

    Takeda Pharmaceuticals International AG

    Diabetes Mellitus, Type 2

    phase 3 small molecule completed

    2 trials

  12. Placebo

    Takeda Pharmaceuticals International AG

    Short Bowel Syndrome

    phase 3 small molecule completed

    1 trial

  13. Placebo

    Takeda Pharmaceuticals International AG

    Male Subjects With Chronic Constipation

    phase 3 small molecule completed

    1 trial

  14. Placebo

    Takeda Pharmaceuticals International AG

    Hypertension

    phase 3 small molecule terminated

    1 trial

  15. Placebo

    Takeda Pharmaceuticals International AG

    Lennox Gastaut Syndrome (LGS)

    phase 3 small molecule completed

    1 trial

  16. Placebo

    Takeda Pharmaceuticals International AG

    Multiple Myeloma

    phase 3 small molecule completed

    1 trial

  17. Placebo

    Takeda Pharmaceuticals International AG

    Diabetes

    phase 3 small molecule terminated

    1 trial

  18. Placebo

    Takeda Pharmaceuticals International AG

    Hypoparathyroidism

    phase 3 small molecule completed

    1 trial

  19. Placebo

    Takeda Pharmaceuticals International AG

    Major Depressive Disorder

    phase 3 small molecule completed

    1 trial

  20. Placebo

    Takeda Pharmaceuticals International AG

    Attention Deficit Hyperactivity Disorder (ADHD)

    phase 3 small molecule completed

    1 trial

  21. Placebo

    Takeda Pharmaceuticals International AG

    Chronic Idiopathic Constipation

    phase 3 small molecule completed

    1 trial

  22. Placebo

    Takeda Pharmaceuticals International AG

    Healthy Volunteers

    phase 3 small molecule completed

    2 trials

  23. Placebo

    Takeda Pharmaceuticals International AG

    Non-erosive Gastroesophageal Reflux Disease

    phase 3 small molecule completed

    1 trial

  24. Ponatinib

    Takeda Pharmaceuticals International AG

    Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)

    phase 3 small molecule active

    1 trial

Frequently asked questions

What is the NovaPharmaNews pipeline directory?

It is a searchable index of 18,156 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.

Where does pipeline data come from?

Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.

How do I find pipeline programs by company or phase?

Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.

Data attribution and licensing: Data sources